Skip to main content
Log in

Chronic hepatitis B: large economic burden with standard treatment

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Janssen Scientific Affairs, LLC.

Reference

  • Sbarigia U, et al. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population. Advances in Therapy : 2 Feb 2020. Available from: URL: http://doi.org/10.1007/s12325-020-01240-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chronic hepatitis B: large economic burden with standard treatment. PharmacoEcon Outcomes News 847, 6 (2020). https://doi.org/10.1007/s40274-020-6582-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6582-2

Navigation